Skip to main content

Table 4 Serious adverse events (SAEs) in the safety population (incidence ≥ 1.0%)

From: Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

Preferred term

Percent of patients N = 902

Patients with at least 1 SAE

15.1

Occurring in ≥ 1% of patients

 

 Syncope

1.3

 Urinary tract infection

1.2

 Fall

1.0

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us